130 related articles for article (PubMed ID: 10083049)
1. Antiphospholipid antibodies in left-ventricular assist system recipients after exposure to topical bovine thrombin.
Fastenau DR; Hormuth DA; McIntyre JA
Transplant Proc; 1999; 31(1-2):141-2. PubMed ID: 10083049
[No Abstract] [Full Text] [Related]
2. Left ventricular assist system recipients exposed to bovine thrombin preparations have a higher frequency of antiphospholipid antibodies than nonexposed recipients.
Fastenau DR; Wagenknecht DR; Hormuth DA; McIntyre JA
ASAIO J; 2001; 47(5):537-40. PubMed ID: 11575833
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibodies after surgical exposure to topical bovine thrombin.
Su Z; Izumi T; Thames EH; Lawson JH; Ortel TL
J Lab Clin Med; 2002 Jun; 139(6):349-56. PubMed ID: 12066133
[TBL] [Abstract][Full Text] [Related]
4. Increased incidence of antiphospholipid antibodies in left ventricular assist system recipients.
Fastenau DR; Wagenknecht DR; McIntyre JA
Ann Thorac Surg; 1999 Jul; 68(1):137-42. PubMed ID: 10421129
[TBL] [Abstract][Full Text] [Related]
5. Immunochemical analysis of polyspecific antibodies in patients exposed to bovine fibrin sealant.
Fastenau DR; McIntyre JA
Ann Thorac Surg; 2000 Jun; 69(6):1867-72. PubMed ID: 10892939
[TBL] [Abstract][Full Text] [Related]
6. Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors.
Berruyer M; Amiral J; Ffrench P; Belleville J; Bastien O; Clerc J; Kassir A; Estanove S; Dechavanne M
J Thorac Cardiovasc Surg; 1993 May; 105(5):892-7. PubMed ID: 8487567
[TBL] [Abstract][Full Text] [Related]
7. Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure.
Streiff MB; Ness PM
Transfusion; 2002 Jan; 42(1):18-26. PubMed ID: 11896308
[TBL] [Abstract][Full Text] [Related]
8. Management of a patient with a mechanical aortic valve and antibodies to both thrombin and factor V after repeat exposure to fibrin sealant.
Zumberg MS; Waples JM; Kao KJ; Lottenberg R
Am J Hematol; 2000 May; 64(1):59-63. PubMed ID: 10815789
[TBL] [Abstract][Full Text] [Related]
9. Severe bleeding due to factor V inhibitor after repeated operations using fibrin sealant containing bovine thrombin.
Muntean W; Zenz W; Edlinger G; Beitzke A
Thromb Haemost; 1997 Jun; 77(6):1223. PubMed ID: 9241765
[No Abstract] [Full Text] [Related]
10. Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosis.
Ortel TL; Charles LA; Keller FG; Marcom PK; Oldham HN; Kane WH; Macik BG
Am J Hematol; 1994 Feb; 45(2):128-35. PubMed ID: 8141118
[TBL] [Abstract][Full Text] [Related]
11. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis.
Singla NK; Ballard JL; Moneta G; Randleman CD; Renkens KL; Alexander WA
J Am Coll Surg; 2009 Jul; 209(1):68-74. PubMed ID: 19651065
[TBL] [Abstract][Full Text] [Related]
12. Acquired inhibitors to factors V and X after exposure to topical thrombin: interference with monitoring of low molecular weight heparin and warfarin.
Israels SJ; Leaker MT
J Pediatr; 1997 Sep; 131(3):480-3. PubMed ID: 9329435
[TBL] [Abstract][Full Text] [Related]
13. Antibodies formed against fibrin glue components and their circulatory relevance.
Seifert J; Klause N; Stobbe J; Egbers HJ
J Invest Surg; 1994; 7(2):167-71. PubMed ID: 8049180
[TBL] [Abstract][Full Text] [Related]
14. Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V.
Bänninger H; Hardegger T; Tobler A; Barth A; Schüpbach P; Reinhart W; Lämmle B; Furlan M
Br J Haematol; 1993 Nov; 85(3):528-32. PubMed ID: 8136275
[TBL] [Abstract][Full Text] [Related]
15. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.
Ofosu FA; Crean S; Reynolds MW
Clin Ther; 2009 Apr; 31(4):679-91. PubMed ID: 19446142
[TBL] [Abstract][Full Text] [Related]
16. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin.
Ortel TL; Mercer MC; Thames EH; Moore KD; Lawson JH
Ann Surg; 2001 Jan; 233(1):88-96. PubMed ID: 11141230
[TBL] [Abstract][Full Text] [Related]
17. Persistence of antibodies to the topical hemostat bovine thrombin.
Randleman CD; Singla NK; Renkens KL; Souza S; Pribble JP; Alexander WA
J Am Coll Surg; 2010 Dec; 211(6):798-803. PubMed ID: 20980172
[TBL] [Abstract][Full Text] [Related]
18. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin.
Zehnder JL; Leung LL
Blood; 1990 Nov; 76(10):2011-6. PubMed ID: 2242423
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the thrombogenicity of internationally available fibrin sealants in an established microsurgical model.
Frost-Arner L; Spotnitz WD; Rodeheaver GT; Drake DB
Plast Reconstr Surg; 2001 Nov; 108(6):1655-60. PubMed ID: 11711942
[TBL] [Abstract][Full Text] [Related]
20. Perioperative topical bovine thrombin exposure is not associated with hemodialysis graft thrombosis.
Vannorsdall MD; Arkel YS; Ku DH; Lucas FL; Himmelfarb J
Kidney Int; 2003 Aug; 64(2):690-6. PubMed ID: 12846767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
